"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 4 | 5 |
| 1997 | 0 | 4 | 4 |
| 1998 | 3 | 1 | 4 |
| 1999 | 6 | 4 | 10 |
| 2000 | 4 | 2 | 6 |
| 2001 | 5 | 6 | 11 |
| 2002 | 6 | 3 | 9 |
| 2003 | 4 | 8 | 12 |
| 2004 | 5 | 4 | 9 |
| 2005 | 7 | 1 | 8 |
| 2006 | 5 | 5 | 10 |
| 2007 | 2 | 10 | 12 |
| 2008 | 6 | 12 | 18 |
| 2009 | 6 | 3 | 9 |
| 2010 | 6 | 6 | 12 |
| 2011 | 10 | 9 | 19 |
| 2012 | 6 | 12 | 18 |
| 2013 | 15 | 10 | 25 |
| 2014 | 12 | 15 | 27 |
| 2015 | 12 | 18 | 30 |
| 2016 | 20 | 19 | 39 |
| 2017 | 24 | 23 | 47 |
| 2018 | 20 | 23 | 43 |
| 2019 | 30 | 21 | 51 |
| 2020 | 19 | 14 | 33 |
| 2021 | 15 | 19 | 34 |
| 2022 | 3 | 26 | 29 |
| 2023 | 2 | 31 | 33 |
| 2024 | 15 | 16 | 31 |
| 2025 | 16 | 9 | 25 |
| 2026 | 9 | 7 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
A novel integrative and conjugative element in Streptococcus pyogenes carries a cfr-like gene associated with linezolid resistance in other species. mSphere. 2026 Sep 29; 11(9):e0027726.
-
Efficacy and safety of oral type II topoisomerase inhibitors versus ceftriaxone-based regimens for the treatment of gonorrhoea: A systematic review and meta-analysis of randomised controlled trials. J Infect Chemother. 2026 Sep; 32(9):103038.
-
Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial. Lancet Oncol. 2026 Aug; 27(8):1043-1056.
-
Beware the tick: ehrlichiosis in a lung transplant recipient. BMJ Case Rep. 2026 Jul 01; 19(7).
-
American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2025 Guidelines for the Management of Infectious and Inflammatory Lesions of the Breast. JAMA Surg. 2026 Jun 01; 161(6):637-645.
-
Identification of Streptococcus pyogenes isolates with reduced beta-lactam susceptibility in a cohort of children with pharyngitis. Antimicrob Agents Chemother. 2026 07; 70(7):e0035426.
-
From gut dysbiosis to eubiosis: understanding microbiome recovery as an ecological process. Gut Microbes. 2026 Dec 31; 18(1):2649448.
-
The intestinal microbiota impacts nutritional immunity and resistance to Acinetobacter baumannii pneumonia. Proc Natl Acad Sci U S A. 2026 Apr 28; 123(17):e2534432123.
-
Clinical presentation and management outcomes of pediatric lung abscess: A retrospective cohort study. PLoS One. 2026; 21(3):e0345174.
-
Evolutionary dynamics and global spread of macrolide-resistant Bordetella pertussis during the post-pandemic pertussis resurgence. J Infect. 2026 Apr; 92(4):106718.